A novel potential therapy for diabetic nephropathy and vascular complications: Protein kinase C beta inhibition
Tuttle KR and Anderson PW. A novel potential therapy for diabetic nephropathy and vascular complications: Protein kinase C b inhibition. Am J Kidney Dis 42:456-465, 2003.
Amino acids induce indicators of response to injury in glomerular mesangial cells
Amino acids induce indicators of response to injury in glomerular mesangial cells
Rick L. Meek,1 Sheryl K. Cooney,1 Stephanie D. Flynn,1 Robert F. Chouinard,1 Maria H. Poczatek,2 Joanne E. Murphy-Ullrich,2 and Katherine R. Tuttle1
Am J Physiol Renal Physiol 285: F79-F86, 2003. First published March 18, 2003; doi:10.1152/ajprenal.00419.2002
0363-6127/03 $5.00
1Research Department, The Heart Institute of Spokane, Spokane, Washington 99204; and 2Division of Molecular and Cellular Pathology, Department of Pathology, and Cell Adhesion and Matrix Research Center, University of Alabama at Birmingham, Birmingham, Alabama 35294
Amino acids induce indicators of response to injury in glomerular mesangial cells.
Meek RL, Cooney SK, Flynn SD, Chouinard RF, Poczatek MH, Murphy-Ulrich JE, Tuttle KR. Amino acids induce indicators of response to injury in glomerular mesangial cells. Am J Physiol 285:F79-F86, 2003.
Is there a pathogenic role for uric acid in hypertension, cardiovascular, and renal disease?
Johnson RJ, Kang D-H, Feig D, Kivlighn S, Kanellis J, Watanabe W, Tuttle KR, Rodriguez-Iturbe B, Hjerrera-Acosta J, Mazzali M. Is there a pathogenic role for uric acid in hypertension, cardiovascular, and renal disease? Hypertension 41:1183-1190, 2003.
Predictors of acute renal failure after cardiac surgical procedures.
Tuttle KR, Worrall NK, Dahlstrom LR, Nandagopal R, Kausz AT, Davis CL. Predictors of acute renal failure after cardiac surgical procedures. Am J Kidney Dis 41:76-83, 2003.
Provision of pharmacy services to underserved populations via remote dispensing and two-way video conferencing
Clifton GD, Byer H, Heaton K, Haberman DJ, Gill H. Provision of pharmacy services to underserved populations via remote dispensing and two-way video conferencing. Am J Healt- Syst Pharm 60:2577-2582, 2003.
Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: Heparin-induced thrombocytopenia in a high-risk cardiac surgical patient
Edwards JT, Hamby JK, Worrall NK. Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: Heparin-induced thrombocytopenia in a high-risk cardiac surgical patient. Ann Thorac Surg 75:1622-1624, 2003.